An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor
Figure 1
Radiologic appearance of IMT lesions in the liver before (a) and after treatment (b) with ALK-inhibitor. (a) MRI of the abdomen with and without Gadolinium before treatment demonstrates vague poorly defined liver masses in the right and left lobes (arrows) each measuring approximately 6-7 cm. (b) CT of the abdomen obtained at 15-month follow-up demonstrates resolution of the ill-defined liver masses bilaterally following treatment with ALK-inhibitor.
